Articles On Cann Group (ASX:CAN)

In afternoon trade the S&P/ASX 200 index is on course to record a disappointing decline. At the time of writing the benchmark index is down 0.75% to 7,079.2 points. Four shares that have not let that hold them back are listed below. He...

Shares in Cann Group Ltd (ASX: CAN) rose to fresh highs for the year yesterday. The Cann Group share price rose 22.55% during the day to close at $1.68, up significantly from Friday’s close of $1.36. The Cann Group share price has since f...

The S&P/ASX 200 index has followed the lead of U.S. markets and pushed higher on Monday. In afternoon trade the benchmark index is up 0.35% to 7,088.3 points. Four shares that are climbing more than most today are listed below. Here’s...

Only one prescription for medical marijuana has been issued by a doctor in the Northern Territory, according to Minister for Health Natasha Fyles. In a submission to the Senate inquiry into barriers to patient access to marijuana, Fyles sai...

In afternoon trade the S&P/ASX 200 index is on course to record another solid gain. At the time of writing the benchmark index is up 0.3% to 6,983.8 points. Four shares that have failed to follow the market higher today are listed belo...

The Cann Group Ltd (ASX: CAN) share price was on form again on Monday and recorded another strong gain. The medicinal cannabis company’s shares raced 13% higher to end the day at $1.07. This latest gain means that Cann Group’s shares have...

In afternoon trade the S&P/ASX 200 index has followed the lead of U.S. markets and is on course to record a strong gain. At the time of writing the benchmark index is up 1% to 6,884.1 points. Four shares that have failed to follow the...

As the world learns tasty cannabis edibles might not be the safest of munchies, Australian investors have served up 19 small cap cannabis stocks as gainers on the ASX. Cannabis edibles are legal in some US states and Canada and just one pro...

The S&P/ASX 200 index is back on form on Tuesday and storming higher this afternoon. At the time of writing the benchmark index is up 1.1% to 6,808.6 points. Not all shares have been able to follow the market higher today. Here’s why t...

Cann Group (CAN) and IDT Australia (IDT) have announced that GMP extraction activities are underway for the first batches of medicinal cannabis resin The extracted resin will be used as an active pharmaceutical ingredient to produce GMP me...

Cann Group (ASX: CAN) and IDT Australia (ASX: IDT) are closer to producing their first medicinal cannabis products with GMP extraction activities now underway. Once extracted, the resin will be used as an active pharmaceutical ingredient fo...

Cann Group’s (ASX: CAN) manufacturer has started making cannabis resin from the company’s plants, and it should be ready for sale by March. The resin needs to be tested for stability before being sold as oil and as an active pharmaceutical...

07 Jan 2020 - The Cann Group (ASX:CAN) and IDT Australia (ASX:IDT) have jointly announced that GMP extraction activities are underway for the first batches of medicinal cannabis re…

The Cann Group Ltd (ASX: CAN) share price has returned from its trading halt and rocketed higher. In morning trade the cannabis company’s shares are up 25% to $1.26. Why is the Cann Group share price rocketing higher on Tuesday? Investors...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

After a morning scare, the ASX managed to pare back its losses to close slightly green. While today’s gains are certainly muted, it’s as good as investors could hope for after a grim night on Wall Street set global markets up for a toug...

Australia’s S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) indices finished higher on Monday. Here’s a short recap of the Australian market: S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) higher 0.03% to...

The Cann Group Ltd (ASX: CAN) share price was the best performer on the All Ordinaries index on Monday before being placed in a trading halt. The cannabis company’s shares were up as much as 28% to $1.03 at one stage today. And were 25.5%...

In afternoon trade the S&P/ASX 200 index is on course to start the week on a disappointing note. At the time of writing the benchmark index is down 0.45% to 6,704.1 points. Four shares that have not let that hold them back today are li...

Last year was a bear market for cannabis stocks globally. During 2019, the excitement that had followed the legalisation of marijuana in many jurisdictions was replaced by cautio as investors realised early forecasts weren’t necessarily ma...

The S&P/ASX 200 index was a strong performer in 2019, ending the year with a return of just over 20% excluding dividends. The benchmark index achieved this despite a number of wobbles along the way. Here are a few ASX lowlights for 201...

In afternoon trade the S&P/ASX 200 index is on course to end the year on a very disappointing note. At the time of writing the benchmark index is down 1.7% to 6,690.5 points. Four shares that have fallen more than most today are listed...

The Cann Group Ltd (ASX: CAN) share price has started the week on an incredibly positive note. At the time of writing the cannabis company’s shares are the best performers on the All Ordinaries index. In afternoon trade they are up a massi...

In afternoon trade the S&P/ASX 200 index is on course to start the week on a disappointing note. At the time of writing the benchmark index is down 0.45% to 6,790.8 points. Four shares that have not let that hold them back today are li...

Shares faded to a two-week low as institutional traders locked in profits at the end of a strong year, and a slew of investment trusts went ex-dividend. The ASX 200 slid 37 points or more than 0.5 per cent to 6784 on holiday-reduced volu...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

This year was a difficult one for ASX cannabis shares as well as cannabis stocks globally with share prices worldwide retreating from previous highs. In Australia the medical marijuana industry remains in its infancy. Nonetheless, the init...

There are many reasons why a company might change its name, from being taken over to hiding a shady past. This year 114 companies have changed their name. Family cyber security provider Wangle Technologies became the much more fitting Famil...

In afternoon trade the S&P/ASX 200 index is having a subdued day of trade ahead of the Christmas break. At the time of writing the benchmark index is flat at 6,785.8 points. Four shares that are performing much better are listed below....

Marijuana is the hottest herb on the planet right now, but while investing in medical cannabis stocks could make you a fortune, it could also risk the house. After a flurry of activity on the ASX in 2017 as the sector kicked off following l...

There is a lot of optimism surrounding the outlook for the multi-billion-dollar global cannabis industry, which may not be still evident from the share prices but increasing number of nations are now introducing proper legal framework to ba...

Cannabis industry is booming at a rapid pace, with several governments creating opportunities for investors by legalising recreational and medicinal cannabis. With increasing legalisation of cannabis, number of investors and entrepreneurs j...

The AusCann Group Holdings Ltd (ASX: AC8) share price certainly was out of form on Thursday. The medicinal cannabis company’s shares were the worst performers on the All Ordinaries with a decline of 13% to 23.5 cents. Why did the AusCann s...

In afternoon trade the S&P/ASX 200 index is on course to finish the day lower. At the time of writing the benchmark index is down 0.1% to 6,843.6 points. Four shares that have not let that hold them back today are listed below. Here’s...

Cann Global (ASX:CGB) has become the second small cap to enter the African cannabis market. It is a market that is estimated to reach $7.1 billion by 2023 although is only legal in three countries including South Africa, Zimbabwe and Lesoth...

Cann Group (ASX: CAN) has confirmed the first commercial medicinal cannabis product to be made at Cann’s Australian-based cultivation operations has been packed by IDT Australia (ASX: IDT) in preparation for commercial release in the new ye...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

In morning trade the Cann Group Ltd (ASX: CAN) share price is rocketing higher. At the time of writing the cannabis company’s shares are up 20% to 51 cents. Why is the Cann Group share price rocketing higher? Investors have been buying Can...

There’s no doubt 2019 has been a difficult year for ASX cannabis shares. Many of the ASX-listed producers have struggled to climb higher and, in many cases, have experienced heavy losses. So is there hope for long-term investors in the Aus...

The Australian share market may have a record high in its sights, but not all shares have been performing as strongly. Three ASX shares that have come under significant pressure this year are listed below. Here’s why they have just hit 52-...

In the global medical cannabis market scenario, Australian cannabis market is the fastest one growing in leaps and bounds. The use of cannabis as a pharmaceutical product for the therapy in severe medical conditions such as Alzheimer’s dise...

The S&P/ASX 200 index has followed the lead of U.S. markets and is dropping lower today. At the time of writing the benchmark index is down 0.15% to 6,719.8 points. Four shares that have fallen more than most today are listed below. He...

Viagra mouth spray maker SUDA Pharmaceuticals (ASX:SUD) has talked a multi-billion dollar pharmaceutical company into backing its tech. Sanofi-Aventis has signed a feasibility agreement to test the mouth spray technology with one of its own...

A significant progress has been seen in Cannabis industry at a global scale, a sector that has witnessed traction and speculation at the same time. Once, a topic of taboo, cannabis is one of the most debated topics worldwide currently.  Can...

Cannabis remains to be a subject of high speculation across the globe, even though significant advancement has been made in this field. A topic of taboo once, cannabis currently is one of the most discussed business opportunities globally,...

Cannabis space is evolving at a rapid pace with Cannabis legalisation changing the landscape across the globe. Cannabis industry is gaining investors attention despite economic pressures, market recklessness and strong competition. Cannabis...

The S&P/ASX 200 index has given back the majority of its morning gains and is trading just a fraction higher this afternoon. At the time of writing the benchmark index is up slightly at 6,868.6 points. Four shares that have failed to f...

Cannabis shares have continued their bumpy ride in November. Marijuana shares globally are trading well down from previous highs, which has impacted our ASX marijuana shares.  The intoxication that greeted the sector earlier this year has...

In the year 2019, marijuana stocks were among the hot picks for investors, despite the general market impulsiveness, strong competition and economic pressures. Recently, a green signal has been given to a bill legalising marijuana on the st...

In afternoon trade the S&P/ASX 200 index is continuing its positive run and looks set to record another solid gain. At the time of writing the benchmark index is up 0.8% to 6,783 points. Four shares that are climbing more than most tod...